Malnutrition and diabetes in tuberculosis treatment programs in the Philippines

Malnutrition and Tuberculosis in the Philippines: prevalence of undernutrition and diabetes in TB control programmes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN12506117

Enrollment

750

Registered

2017-05-19

Start date

2017-05-01

Completion date

Unknown

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis, malnutrition, diabetes Nutritional, Metabolic, Endocrine Tuberculosis, malnutrition, diabetes

Interventions

In this cross-sectional study, participants are randomly sampled as to when they are surveyed for data collection. This could be during their first week of TB treatment or their final week of treatmen

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. All registered TB DOTS patients at preselected clinics. This includes those with MDR TB, co-infection with HIV, and those with pre-existing diabetes or other co-morbidities. 2. Aged 18 and older

Exclusion criteria

Exclusion criteria: Pregnant women.

Design outcomes

Primary

Measure	Time frame
1. Prevalence of clinical wasting (BMI 6.5%) through a blood prick test or previous diagnosis at time of study enrollment	—

Secondary

Measure	Time frame
1. Factors associated with malnutrition (age, sex, region, duration of treatment, programme compliance, household food security and appetite) are measured using patient treatment cards at time of study enrollment 2. Prevalence of drug related side effects are measured using patient interview at time of study enrollment and one month 3. Handgrip strength measured using a strain-gauge based isometric Jamar Hand Dynamometer at time of study enrollment 4. BMI is measured using participants weight and height at time of study enrollment 5. Mid-upper arm circumference is measured using SECA measuring tape at time of study enrollment 6. Diabetes management is measured using patient interview at time of study enrollment 7. Anaemia is measured using hemoglobin value (obtained using Hemocue 301+ point of care test) at time of study enrollment 8. Quality of life is measured using the WHO Quality of Life BREF survey at time of study enrollment 9. Patient related compliance (in the last week) is measured using interviews and document compliance through patient treatment cards at time of study enrollment	—

Measure

Time frame

1. Factors associated with malnutrition (age, sex, region, duration of treatment, programme compliance, household food security and appetite) are measured using patient treatment cards at time of study enrollment 2. Prevalence of drug related side effects are measured using patient interview at time of study enrollment and one month 3. Handgrip strength measured using a strain-gauge based isometric Jamar Hand Dynamometer at time of study enrollment 4. BMI is measured using participants weight and height at time of study enrollment 5. Mid-upper arm circumference is measured using SECA measuring tape at time of study enrollment 6. Diabetes management is measured using patient interview at time of study enrollment 7. Anaemia is measured using hemoglobin value (obtained using Hemocue 301+ point of care test) at time of study enrollment 8. Quality of life is measured using the WHO Quality of Life BREF survey at time of study enrollment 9. Patient related compliance (in the last week) is measured using interviews and document compliance through patient treatment cards at time of study enrollment

—

Countries

Philippines

Contacts

Public ContactLaura White

laurawhite@nagasaki-u.ac.jp+63 921 301 1934

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026